Pfizer

PFE · Health Care · Market cap $141B

Q1 FY26 Mar 29, 2026 reported May 5, 2026

Revenue$14.5B +5% year over year

Gross profit$10.9B

Operating profit$-3.2B

Net profit$2.7B 19% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 29, 2026).
Item	Value	Share of revenue	Year over year
Revenue	14.5	100%	+5%
US	8.7	60%	+4%
International Developed Markets	3.4	23%	+8%
International Emerging Markets	2.3	16%	+6%
Cost of revenue	−3.5	24%
Gross profit	10.9	75% margin	−4pp
SG&A	−3	20%	−2pp
Other	−11.1	77%	+0pp
Operating profit	-3.2	-22% margin	+0pp
Tax	−0.4
Net profit	2.7	19%	−3pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	16.7	100%	−6%
US	10.7	64%	−11%
International Developed Markets	3.7	22%	+8%
International Emerging Markets	2.3	14%	+2%
Cost of revenue	−4.2	25%
Gross profit	12.5	75% margin	+5pp
SG&A	−3.2	19%	+1pp
Other	−12.8	77%	+0pp
Operating profit	-3.5	-21% margin	+0pp
Net profit	3.5	21%	−4pp

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 29, 2025).
Item	Value	Share of revenue	Year over year
Revenue	14.7	100%	+10%
US	8.9	61%	+13%
International Developed Markets	3.4	23%	+7%
International Emerging Markets	2.4	16%	+6%
Cost of revenue	−3.8	26%
Gross profit	10.9	74% margin	−1pp
SG&A	−3.4	23%	−5pp
Other	−10.5	72%	+0pp
Operating profit	-3.1	-21% margin	+0pp
Tax	−0.1
Net profit	2.9	20%	+20pp

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	13.7	100%	−8%
US	8.4	61%	−12%
International Developed Markets	3.2	23%	−1%
International Emerging Markets	2.2	16%	+0%
Cost of revenue	−2.8	20%
Gross profit	10.9	79% margin	+2pp
SG&A	−3	22%	−1pp
Other	−10.8	79%	+0pp
Operating profit	-3	-22% margin	+0pp
Net profit	3	22%	+1pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q1 FY26	Mar 29, 2026	May 5, 2026	$14.5B	+5%	-22%	$2.7B	19%
Q3 FY25	Jun 30 – Sep 28, 2025	Nov 4, 2025	$16.7B	−6%	-21%	$3.5B	21%
Q2 FY25	Mar 31 – Jun 29, 2025	Aug 5, 2025	$14.7B	+10%	-21%	$2.9B	20%
Q1 FY25	Jan 1 – Mar 30, 2025	May 5, 2025	$13.7B	−8%	-22%	$3B	22%